3.1 Identification of major chemical components
In preliminary experiment, the samples were comprehensively analyzed in both positive and negative ion mode under the optimized conditions. It was found that the sensitivity in negative ion mode was higher than in positive ion mode, and thus negative ion mode was applied to obtain fragmentation information of compounds in the study to capture base peak ion chromatograms (Fig. 1). Molecular formula of chemical constituents was accurately characterized in combination with MS analysis, CR database built in-home as well as related literature. In total, 28 compounds were identified from CR and RCR, which were considered as 7 types according to carbon skeletons, including 12 organic acids, 6 phenylpropanoids, 5 hexanol glycosides and hexylene glycosides, 2 polyacetylenes, 1 alcohol compound, 1 sesquiterpene and 1 aldehyde (Table 2).
Table 2
Components identified in CR and RCR
No.
|
RT
(min)
|
Formula
|
Precursor ion
|
ppm
|
MS2 fragment ions in negative mode
|
Compound name
|
Type
|
Source
|
Peak area ratio
(CR: RCR)
|
CR
|
RCR
|
1
|
3.15
|
C4H6O4
|
117.0192[M-H]−
|
1.60
|
-
|
Succinic acid
|
a
|
+
|
+
|
0.88
|
2
|
5.10
|
C6H6O3
|
125.0251[M-H]−
|
-7.24
|
-
|
5- HMF *
|
b
|
-
|
+
|
-
|
3
|
12.48
|
C7H6O3
|
137.0240[M-H]−
|
2.10
|
119.0261[M-H-H2O]−
|
4-Hydroxybenzoic acid
|
a
|
+
|
+
|
1.11
|
4
|
14.51
|
C17H24O9
|
417.1406[M + HCOO]−
|
0.80
|
371.1281[M-H]−
210.0767[M-H-C6H10O5]−
|
Syringin
|
c
|
+
|
+
|
1.18
|
5
|
16.65
|
C18H32O11
|
423.1865[M-H]−
|
1.84
|
261.0986[M-H-C6H10O5]−
|
Trans-2-hexenyl-β-glucoside
|
d
|
+
|
+
|
0.78
|
6
|
19.69
|
C18H32O11
|
423.1867[M-H]−
|
1.05
|
261.0985[M-H-C6H10O5]−
|
Cis-2-hexenyl-β-glucoside
|
d
|
+
|
+
|
1.25
|
7
|
20.05
|
C29H42O18
|
677.2288[M-H]−
|
1.34
|
497.1661[M-H-C6H12O6]−
453.1402[M-H-C6H12O6-CO2]−
|
Tangshenoside I
|
c
|
+
|
+
|
1.23
|
8
|
20.45
|
C15H18O8
|
325.0925[M-H]−
|
1.45
|
163.0402[M-H-C6H10O5]−
119.0502[M-H-C6H10O5-CO2]−
|
4-O-beta-glucopyranosyl-cis-coumaric acid
|
c
|
+
|
+
|
1.05
|
9
|
21.58
|
C18H34O11
|
471.2077[M + HCOO]−
|
2.10
|
425.2016[M-H]−
263.1487[M-H-C6H10O5]−
|
Hexy-β-a-glucopyranosyl-(1→2)-β-a-glucopyranoside
|
d
|
+
|
+
|
0.57
|
10
|
22.43
|
C18H34O11
|
425.2026[M-H]−
|
1.33
|
263.1438[M-H-C6H10O5]−
|
Hexy-β-a-glucopyranosyl-(1→6)-β-a-glucopyranoside
|
d
|
+
|
+
|
0.61
|
11
|
23.42
|
C21H26O12
|
469.1351[M-H]−
|
-0.21
|
325.1046[M-H-C6H8O4]−
163.0393[M-H-C6H8O4-C6H10O5]−
|
Tangshenoside V
|
c
|
+
|
+
|
2.20
|
12
|
24.91
|
C17H32O10
|
395.1916[M-H]−
|
0.64
|
263.1473[M-H-C5H8O4]−
101.0355[M-H-C5H8O4-C6H10O5]−
|
Pentose aldose glucose-n-hexanoside
|
d
|
+
|
+
|
1.00
|
13
|
25.31
|
C26H38O13
|
603.2292[M + HCOO]−
|
-0.52
|
557.2239[M-H]−
467.1710[M-H-C7H6]−
395.1934[M-H-C6H10O5]−
|
Lobetyolinin
|
e
|
+
|
+
|
1.28
|
14
|
28.63
|
C38H48O20
|
823.2652[M-H]−
|
1.92
|
497.1041[M-H-C15H18O8]−
452.9206[M-H-C15H18O8-CO2]−
|
Codonoside B
|
c
|
+
|
+
|
1.08
|
15
|
28.87
|
C20H28O8
|
441.1780[M + HCOO]−
|
-4.48
|
395.1922[M-H]−
215.1083[M-H-C6H12O6]−
|
Lobetyolin *
|
e
|
+
|
+
|
1.42
|
16
|
30.40
|
C38H48O20
|
823.264[M-H]−
|
2.52
|
497.1040[M-H-C15H18O8]−
452.9196[M-H-C15H18O8-CO2]−
|
Codonoside A
|
c
|
+
|
+
|
2.08
|
17
|
31.89
|
C9H16O4
|
187.0980[M-H]−
|
2.67
|
169.0860[M-H-H2O]−
125.0971[M-H-H2O-CO2]−
|
Azelaic acid
|
a
|
+
|
+
|
0.97
|
18
|
37.52
|
C18H32O5
|
327.2176[M-H]−
|
0.32
|
229.1405[M-H-C6H10O]−
211.1351[M-H-C6H10O-H2O]−
|
Malyngic acid
|
a
|
+
|
+
|
1.56
|
19
|
39.10
|
C18H34O5
|
329.2337[M-H]−
|
-0.96
|
229.1436[M-H-C6H12O]−
211.1340[M-H-C6H12O-H2O]−
|
Tianshi acid
|
a
|
+
|
+
|
1.50
|
20
|
43.46
|
C18H30O4
|
309.2057[M-H]−
|
4.84
|
291.1772[M-H-H2O]−
|
6-Methylgingediol
|
f
|
+
|
+
|
2.06
|
21
|
44.09
|
C9H16O2
|
311.2255[2M-H]−
|
-8.10
|
155.1068[M-H]−
127.1127[M-H-C2H4]−
|
8-Nonenoic acid
|
a
|
+
|
+
|
0.62
|
22
|
44.50
|
C15H20O3
|
247.1352[M-H]−
|
2.28
|
203.1445[M-H-CO2]−
|
Atractylenolide III *
|
g
|
+
|
+
|
1.01
|
23
|
46.30
|
C18H34O4
|
313.2397[M-H]−
|
-4.07
|
201.1137[M-H-C8H16]−
|
Leukotoxin diol
|
a
|
+
|
+
|
0.73
|
24
|
46.93
|
C9H16O2
|
311.2233[2M-H]−
|
-2.13
|
155.1065[M-H]−
|
2-Nonenoic acid
|
a
|
+
|
+
|
13.45
|
25
|
51.07
|
C18H32O3
|
295.2287[M-H]−
|
1.31
|
277.2159[M-H-H2O]−
|
Coronaric acid
|
a
|
+
|
+
|
3.12
|
26
|
59.63
|
C18H30O2
|
277.2186[M-H]−
|
-5.67
|
233.1137[M-H-CO2]−
|
5,9,12-Octadecatrienoic acid
|
a
|
+
|
+
|
1.52
|
27
|
62.78
|
C18H32O2
|
279.2334[M-H]−
|
-1.65
|
261.2221[M-H-H2O]−
|
(9Z,12Z)-Octadeca-9,12-dienoic acid
|
a
|
+
|
+
|
1.63
|
28
|
65.98
|
C16H32O2
|
255.2327[M-H]−
|
2.48
|
237.2202[M-H-H2O]−
|
Palmitic acid
|
a
|
+
|
+
|
1.26
|
Type: a-organic acids; b-aldehyde compound; c-phenylpropanoids; d-hexanol glycosides and hexylene glycosides; e-polyacetylenes; f-alcohol compound; g-sesquiterpene |
* Identified as compound in standards. |
Figure 1 Base peak ion chromatograms of CR (a) and RCR (b) in negative ionization mode.
Table 2 Components identified in CR and RCR
3.1.1 Structural characterization and identification of aldehyde
By comparison with mass data of literature, compound 2 was tentatively ascertained as 5-HMF [15], a crucial ingredient only in the processed product to differentiate CR from RCR, displaying a precursor the [M-H]− ion at m/z 125.0241 (C6H6O3, mass error = -7.24 ppm). The spectrum of MS analysis and molecular structure of compound 2 was shown in Fig. 2.
Figure 2 The mass spectra and the molecular structure of 5-HMF in negative ion mode. (a) mass spectra; (b) molecular structure.
3.1.2 Structural characterization and identification of organic acids
There were 12 constituents classified as organic acid from CR and RCR, and the trend of changed content of organic acid could be determined preliminarily by comparing peak area of these chemical components, presenting declines in 8 kinds of organic acids contents to varying degrees except for compounds 1, 17, 21 and 23. Generally, destruction and decomposition of organic acids would occur with heating-processed [30], thus making content decreased. Research has shown that excessive acidic compositions were liable to irritation, especially adverse effects on patients with weakness or ulcers [31]. Therefore, organic acid with a content decline in RCR shown correspondingly lower irritation, which might be related to supplementing deficiency and protecting spleen and stomach of RCR.
Compound 1 generated a quasi-molecular ion at m/z 117.0192 [M-H]− with molecular formula C4H6O4 (mass error = 1.60 ppm). Comparing with the literature data[16], compound 1 was tentatively identified as succinic acid.
Compound 3 showed [M-H]− ion at m/z 137.0240, and was further fragmented into product ion at m/z 119.0261, resulting from the neutral loss of H2O [32]. In combination with the literature data [33], compound 3 was tentatively annotated as 4-hydroxybenzoic acid.
Compound 17 exhibited its quasi-molecular ion at m/z 187.0971[M-H]− with molecular formula C9H16O4. In addition, the precursor ion generated characteristic fragment ions at m/z 169.0860 [M-H-H2O]− and 125.0969 [M-H-H2O-CO2]− in the MS2 spectrum, suggesting the neutral loss of H2O followed by losing CO2. Based on relevant literature [33], compound 17 was tentatively identified as azelaic acid, and its MS/MS spectra and fragmentation pathway were exhibited in Fig. 3.
Figure 3 The MS/MS spectra and the fragmentation pathways of azelaic acid in negative ion mode. (a) MS/MS spectra; (b) fragmentation pathways.
Compound 18 produced a quasi-molecular ion at m/z 327.2176[M-H]− with molecular formula C18H32O5. The deprotonated molecular ions further generated a series of ions at m/z 229.1405 [M-H-C6H10O]− and m/z 211.1351 [M-H-C6H10O-H2O]−, which was tentatively identified as malyngic acid. Compound 19 with elemental composition of C18H34O5 shared the similar route to generate fragment ions as above. Combining with the reported data [34], compound 19 was tentatively ascertained as tianshi acid.
Compound 21 and 24 were a pair of isomers with identical molecular formula C9H16O2. Both of them exhibited [2M-H]− at m/z 311.2255, and deprotonated molecular ions at m/z 155.1068 [M-H]− in spectra, which were primarily identified 4-nonenoic acid/ 8-nonenoic acid. The characteristic fragmentation of [M-H-C2H4]− at m/z 127.1127 contributed to confirmation of 8-nonenoic acid due to the loss of C2H4. By combining with mass spectrometry information and related literature[16], compound 21 was tentatively identified to be 8-nonenoic acid, while compound 24 was annotated as 2-nonenoic acid.
Compound 23 yielded molecular ion at m/z 313.2397 [M-H]− with molecular formula C18H34O4. The characteristic fragment ion at m/z 201.1137 [M-H-C8H16]− was observed in MS2 spectra. According to the information of literature[34], it was tentatively characterized as leukotoxin diol.
Compound 25 displayed precursor ion at m/z 295.2277[M-H]− with molecular formula C18H32O3. It generated fragment ions at m/z 277.2164 [M-H-H2O]−, resulting from the neutral loss of H2O. By comparison with references [33], compound 25 was identified as coronaric acid.
Compound 26 yielded its quasi-molecular ion at m/z 277.2186 [M-H]− with molecular formula C18H30O2. The [M-H]− ion generated fragment ions at m/z 233.1137 [M-H-CO2]−, caused by the neutral loss of CO2. Therefore, compound 26 was ascertained as 5,9,12-octadecatrienoic acid [34].
Compound 27 yielded quasi-molecular ion at m/z 279.2334[M-H]− with elemental composition of C18H32O2 (mass error = -1.65 ppm). Characteristic ion at m/z 261.2221 [M-H-H2O]− was observed after eliminating neutral fragments of H2O. Hence, compound 27 tentatively identified as (9Z,12Z)-octadeca-9,12-dienoic acid based on mass data.
Compound 28 showed [M-H]− ion at m/z 255.2327, and product ions at m/z 237.2202[M-H-H2O]− were obtained by loss of H2O in MS/MS spectra. By comparison the literature data[35], compound 28 was tentatively determined as palmitic acid.
3.1.3 Structural characterization and identification of phenylpropanoids
Compound 4 exhibited a quasi-molecular ion m/z 417.1406 [M + HCOO]− with molecular formula C17H24O9. It could generate fragment ions at m/z 371.1281 [M-H]− and m/z 209.0767 [M-H-C6H10O5]−. According to the reported data [16], compound 4 was characterized as syringin.
Compound 7 produced its precursor ion at m/z 677.2288 [M-H]− with molecular formula C29H42O18 (Fig. 4). The molecular ion generated fragment ions at m/z 497.1661 [M-H-C6H12O6]− and m/z 453.1402 [M-H-C6H12O6-CO2]−, which originated from the neutral loss of C6H12O6 and CO2. Comparing with the information of literature [34], compound 7 was tentatively deduced as tangshenoside I.
Figure 4 The MS/MS spectra and the fragmentation pathways of tangshenoside I in negative ion mode. (a) MS/MS spectra; (b) fragmentation pathways.
Compounds 8 yielded deprotonated molecular ions at m/z 325.0925 [M-H]−, and a glucose residue C6H10O5 was eliminated in MS/MS spectrum to form characteristic fragment at m/z 163.0402 [M-H-C6H10O5]−, followed by neutral loss of CO2 presenting m/z 119.0502 [M-H-C6H10O5-CO2]−. Compound 8 was therefore deduced to be 4-o-beta-glucopyranosyl-cis-coumaric acid combining multi-stage ions information of MSn with relevant literatures [16].
Compound 11 generated precursor ion at m/z 469.1351 [M-H]− with molecular formula C21H26O12. The molecular ion was further fragmented into ions at m/z 325.1046 [M-H-C6H8O4]− and m/z 163.0393 [M-H-C6H8O4-C6H10O5]−, resulting from the loss of C6H8O4, after that the loss of C6H10O5. According to the literature data[36], compound 11 was accurately identified as tangshenoside V.
Compound 14 produced [M-H]− ion at m/z 823.2652, and product ions were further generated at m/z 497.104 1[M-H-C15H18O8]− and m/z 452.9206 [M-H-C15H18O8-CO2]− corresponding to the loss of C15H18O8 and CO2. Compound 16 shared an identical elemental composition of C38H48O20 as compound 14, and its fragmentation pathway was in accord with that of compound 4. Codonoside B with higher polarity than Codonoside A was faster eluted on reversed phase chromatography, therefore, compound 14 and compound 16 were distinguished as Codonoside B and Codonoside A [33].
3.1.4 Structural characterization and identification of hexanol glycosides and hexylene glycosides
Compounds 5 and 6 were identified primarily as isomers by identical quasi-molecular ions at m/z 423.1865 [M-H]− with elemental composition of C18H32O11, and their deprotonated molecular ion generated [M-H-C6H10O5]− at m/z 261.0986, resulting from the loss of the C6H10O5. They were further differentiated by retention time. Trans-2-hexenyl-β-glucoside performed stronger polar than cis-2-hexenyl-β-glucoside, thus was eluted with shorter retention time on reversed phase chromatography. Combining characteristic of the compound and literature data [34], compound 5 and compound 6 were assigned as trans-2-hexenyl-β-glucoside and cis-2-hexenyl-β-glucoside.
Compound 9 generated deprotonated ion at m/z 471.2077 [M + HCOO]−, and fragment ions at m/z 425.2016 [M-H]− was observed by losing HCOOH. In addition, the molecular ion yielded [M-H-C6H10O5] at m/z 263.1487 due to the loss of glucose. Consequently, according to the literature data[16], compound 9 was tentatively identified as hexy-β-a-glucopyranosyl-(1→2)-β-a-glucopyranoside. Compound 10 had the same elemental composition of C18H34O11 as compound 9, which fragmentation pathway was similar as above. Comparing with the literature [16], compound 10 was tentatively identified as hexy-β-a-glucopyranosyl-(1→6)-β-a-glucopyranoside.
Compound 12 produced a deprotonated ion m/z 395.1916[M-H]− with molecular formula C17H32O10. Product ions at m/z 263.1473 [M-H-C5H8O4]− and m/z 101.0355 [M-H-C5H8O4-C6H10O5]− were generated by continuously losing of pentose and glucose. MS/MS spectra and proposed fragmentation pathway of compound 12 were displayed in Fig. 5, and it was predicatively identified as pentose aldose glucose-n-hexanoside by comparing mass data with the reported data [34].
Figure 5 The MS/MS spectra and the fragmentation pathways of pentose aldose glucose-n-hexanoside in negative ion mode. (a) MS/MS spectra; (b) fragmentation pathways.
3.1.5 Structural characterization and identification of polyacetylenes
Compound 13 exhibited its quasi-molecular ion m/z 603.2292 [M + HCOO]− with molecular formula C26H38O13. It generated a series of ions at m/z 557.2239 [M-H]−, m/z 467.1710 [M-H-C7H6]− and m/z 395.1934 [M-H-C6H10O5]−, arising from sequential elimination of HCOOH, C7H6 and glucose. Compound 13 was predicatively identified as lobetyolinin based on literature data[16].
Compound 15 produced its [M + HCOO]− ion at m/z 441.1780 with molecular formula C20H28O8 (mass error = -4.48 ppm). In MS spectrum, it yielded typical ions at m/z 395.1922 [M-H]− and m/z 215.1083 [M-H-C6H12O6]−, shown in Fig. 6. Therefore, comparing with the literature[33], compound 15 was confirmed as lobetyolin.
Figure 6 The MS/MS spectra and the fragmentation pathways of lobetyolin in negative ion mode. (a) MS/MS spectra; (b) fragmentation pathways.
3.1.6 Structural characterization and identification of alcohol compound
Compound 20 exhibited precursor ion at m/z 309.2057 [M-H]− with molecular formula C18H30O4 (Fig. 7), and further generated product ions at m/z 291.1772 [M-H-H2O]−, resulting from the neutral loss of H2O. According to the related literature[33], compound 20 was unambiguously identified as 6-methylgingediol.
Figure 7 The MS/MS spectra and the fragmentation pathways of 6-methylgingediol in negative ion mode. (a) MS/MS spectra; (b) fragmentation pathways.
3.1.7 Structural characterization and identification of sesquiterpenes
Compound 22 yielded the [M-H]− ion at m/z 247.1352 (C15H20O3, mass error = -2.28 ppm). As shown in Fig. 8, fragment ion at m/z 203.1455 [M-H-CO2]− was obtained in MS/MS spectra. Therefore, comparing with the reported data [16], compound 22 was tentatively identified as atractylenolide III.
Figure 8 The MS/MS spectra and the fragmentation pathways of atractylenolide III in negative ion mode. (a) MS/MS spectra; (b) fragmentation pathways.
3.3 Quantitative results
The optimized method was performed to estimate dynamic changes of chemical constituents of multiple CR products in processing. In view of sensitivity and specificity of triple quadrupole mass analyzer suitable for accurate quantification, HPLC-QQQ-MS was used to measure contents of lobetyolin and atractylenolide III. Total ion chromatograms for quantifying lobetyolin and atractylenolide III in CR and RCR were shown in Fig. S4. In addition, 5-HMF with strong polar could be eluted fast by HPLC, which was a convenient detection method with relatively low cost. CPPS was well measured by phenol-sulphuric acid method. Overall, lobetyolin, atractylenolide III, 5-HMF and CPPS were characteristic components to distinguish between raw CR and RCR.
The quantitative results of these four active constituents were displayed in Table 4, and their content changing trends were shown in Fig. 9. The content of lobetyolin increased occasionally in the process samples due to sampling errors, but it showed a downward trend as a whole, especially that lobetyolin significantly decreased in RCR compared with crude CR. Similarly, though a rise of atractylenolide III contents in individual samples with processing time, it eventually appeared to be falling after rice-processing. From the fifth minute of the processing, 5-HMF was produced and increased in content gradually. Furthermore, the change of CPPS content showed a overall tendency to reduce during processing.
Table 4
The determination results of compounds in RC and RCR
Sample
|
Lobetyolin
(mg/g)
|
Atractylenolide III
(mg/g)
|
5-HMF
(mg/g)
|
CPPS
(%)
|
CR
|
0.2994
|
0.0445
|
-
|
8.10
|
CR-1
|
0.3266
|
0.0448
|
-
|
7.68
|
CR-2
|
0.3796
|
0.0373
|
-
|
7.65
|
CR-3
|
0.2981
|
0.0415
|
-
|
8.21
|
CR-4
|
0.3273
|
0.0400
|
-
|
8.48
|
CR-5
|
0.3535
|
0.0431
|
-
|
8.44
|
CR-6
|
0.3920
|
0.0399
|
0.0326
|
7.48
|
CR-7
|
0.3073
|
0.0400
|
0.0416
|
6.97
|
CR-8
|
0.3224
|
0.0369
|
0.0607
|
7.72
|
CR-9
|
0.2527
|
0.0362
|
0.0748
|
6.54
|
CR-10
|
0.2807
|
0.0360
|
0.0862
|
5.82
|
CR-11
|
0.2426
|
0.0350
|
0.0984
|
5.27
|
RCR
|
0.2118
|
0.0384
|
0.1176
|
5.26
|
Figure 9 The contents of lobetyolin, atractylenolide III, 5-HMF and CPPS in CR and multiple rice-stirring products.